Full Text View
Tabular View
No Study Results Posted
Related Studies
The Impact of Rosiglitazone on Regression of Atherosclerosis
This study has suspended participant recruitment.
( no fund )
Study NCT00166803   Information provided by National Taiwan University Hospital

First Received on September 11, 2005.   Last Updated on January 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Atherosclerosis
Additional conditions recognized in this trial
Atherosclerosis
Diabetes Mellitus
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
Rosiglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Taiwan University Hospital
National Science Council, Taiwan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services